XTL Biopharmaceuticals Ltd. (XTLB) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    XTL Biopharmaceuticals Lt...

    NASDAQ: XTLB · Real-Time Price · USD
    1.18
    0.01 (0.85%)
    At close: Oct 03, 2025, 3:48 PM
    1.17
    -0.85%
    After-hours: Oct 03, 2025, 04:00 PM EDT

    XTL Biopharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -1.03M -1.78M -1.35M 435K
    Depreciation & Amortization
    		 199K n/a 1K 1K
    Stock-Based Compensation
    		 264K 3K 14K 37K
    Other Working Capital
    		 -58K 45K 25K -31K
    Other Non-Cash Items
    		 -1.11M 1.01M -36K -1.47M
    Deferred Income Tax
    		 -130K n/a 487K n/a
    Change in Working Capital
    		 189K 64K -19K -54K
    Operating Cash Flow
    		 -1.62M -707K -901K -1.05M
    Capital Expenditures
    		 -54K n/a n/a n/a
    Cash Acquisitions
    		 -410K n/a n/a n/a
    Purchase of Investments
    		 -14K n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 -366K 41K 36K 8K
    Investing Cash Flow
    		 -844K 41K 36K 8K
    Debt Repayment
    		 -13K n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a n/a n/a n/a
    Financial Cash Flow
    		 1.45M n/a n/a 385K
    Net Cash Flow
    		 -1.03M -693K -875K -662K
    Free Cash Flow
    		 -1.67M -707K -901K -1.05M

    Add to Watchlist